---
title: "DLBCL Prognostic Gene Signatures"
subtitle: "Genome-Wide Survival Analysis by Cell of Origin"
author: "HMRN/Lacy Cohort Analysis"
date: "`r Sys.Date()`"
output:
  beamer_presentation:
    theme: "Madrid"
    colortheme: "dolphin"
    fonttheme: "structurebold"
    slide_level: 2
    fig_caption: false
    keep_tex: false
header-includes:
  - \usepackage{booktabs}
  - \usepackage{graphicx}
  - \setbeamertemplate{navigation symbols}{}
  - \setbeamertemplate{footline}[frame number]
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(
  echo = FALSE,
  warning = FALSE,
  message = FALSE,
  fig.align = "center",
  out.width = "85%"
)

base_dir <- "C:/Users/ericp/OneDrive/Desktop/Claude-Projects/Claude-Project-06"
fig_dir <- file.path(base_dir, "global_scripts/figures")
```

# Introduction

## Study Overview

\begin{columns}
\begin{column}{0.5\textwidth}
\textbf{Objective:}
\begin{itemize}
\item Identify prognostic gene signatures in DLBCL
\item Compare across Cell of Origin (COO) subtypes
\item Test independence from IPI
\end{itemize}
\end{column}
\begin{column}{0.5\textwidth}
\textbf{Key Questions:}
\begin{itemize}
\item Which genes predict survival?
\item Are signatures COO-specific?
\item Do they add value beyond IPI?
\end{itemize}
\end{column}
\end{columns}

## Study Cohort

```{r cohort, out.width="80%"}
knitr::include_graphics(file.path(fig_dir, "cohort_overview.png"))
```

- **HMRN/Lacy Cohort** (GSE181063): 1,303 samples with survival data
- **Platform**: Illumina HumanHT-12 V4 BeadChip (29,372 probes)

# Methodology

## Analysis Pipeline

```{r methodology, out.width="95%"}
knitr::include_graphics(file.path(fig_dir, "methodology_diagram.png"))
```

## Statistical Methods

\begin{columns}
\begin{column}{0.5\textwidth}
\textbf{Univariate Analysis:}
$$h(t|x) = h_0(t) \cdot e^{\beta x}$$
\begin{itemize}
\item Cox proportional hazards
\item Per-probe regression
\item Z-score normalized expression
\end{itemize}
\end{column}
\begin{column}{0.5\textwidth}
\textbf{Multiple Testing:}
\begin{itemize}
\item Benjamini-Hochberg FDR
\item Significance: FDR < 0.05
\end{itemize}
\vspace{0.5cm}
\textbf{IPI Adjustment:}
$$h(t|x,IPI) = h_0(t) \cdot e^{\beta_1 x + \beta_2 IPI}$$
\end{column}
\end{columns}

# Results: Global Analysis

## Volcano Plot - Global Survival Analysis

```{r volcano, out.width="85%"}
knitr::include_graphics(file.path(fig_dir, "volcano_global.png"))
```

## Key Findings - Global

\begin{columns}
\begin{column}{0.5\textwidth}
\textbf{Significant Probes:}
\begin{itemize}
\item \textbf{6,748} FDR < 0.05
\item \textbf{3,243} Protective (HR < 1)
\item \textbf{3,505} Adverse (HR > 1)
\end{itemize}
\end{column}
\begin{column}{0.5\textwidth}
\textbf{Top Genes:}

\footnotesize
\begin{tabular}{ll}
\toprule
\textbf{Protective} & \textbf{Adverse} \\
\midrule
SIRPG & POLR3G \\
CD3D, CD3E & EXO1 \\
MMP9 & C19orf48 \\
BCL11B & UBE2Q2P2 \\
LCK, CD2 & SHCBP1 \\
\bottomrule
\end{tabular}
\end{column}
\end{columns}

## Prognostic Signature Heatmap

```{r heatmap-global, out.width="95%"}
knitr::include_graphics(file.path(fig_dir, "heatmap_global_signature.png"))
```

## Kaplan-Meier: Global Signature

```{r km-global, out.width="80%"}
knitr::include_graphics(file.path(fig_dir, "km_global_signature.png"))
```

# Pathway Enrichment (GSEA)

## Protective Pathways

```{r gsea-prot, out.width="90%"}
knitr::include_graphics(file.path(fig_dir, "gsea_protective_barplot.png"))
```

## Adverse Pathways

```{r gsea-harm, out.width="90%"}
knitr::include_graphics(file.path(fig_dir, "gsea_adverse_barplot.png"))
```

## Combined Pathway Analysis

```{r gsea-combined, out.width="90%"}
knitr::include_graphics(file.path(fig_dir, "gsea_combined_dotplot.png"))
```

## Pathway Summary

\begin{columns}
\begin{column}{0.5\textwidth}
\textbf{Protective Pathways:}
\begin{itemize}
\item \textcolor{green!70!black}{Allograft Rejection}
\item \textcolor{green!70!black}{IL-2/STAT5 Signaling}
\item \textcolor{green!70!black}{T-cell Activation}
\item \textcolor{green!70!black}{Immune Surveillance}
\end{itemize}
\vspace{0.3cm}
$\Rightarrow$ \textbf{T-cell infiltration = Good prognosis}
\end{column}
\begin{column}{0.5\textwidth}
\textbf{Adverse Pathways:}
\begin{itemize}
\item \textcolor{red}{E2F Targets}
\item \textcolor{red}{G2M Checkpoint}
\item \textcolor{red}{DNA Repair/HDR}
\item \textcolor{red}{MYC Targets}
\end{itemize}
\vspace{0.3cm}
$\Rightarrow$ \textbf{Proliferation = Poor prognosis}
\end{column}
\end{columns}

# COO-Specific Signatures

## Significant Genes by COO Subset

```{r coo-comparison, out.width="85%"}
knitr::include_graphics(file.path(fig_dir, "coo_comparison.png"))
```

## GCB-Specific Signature

```{r heatmap-gcb, out.width="85%"}
knitr::include_graphics(file.path(fig_dir, "heatmap_gcb_signature.png"))
```

## ABC-Specific Signature

```{r heatmap-abc, out.width="85%"}
knitr::include_graphics(file.path(fig_dir, "heatmap_abc_signature.png"))
```

## COO Pathway Comparison

```{r gsea-coo, out.width="95%"}
knitr::include_graphics(file.path(fig_dir, "gsea_coo_comparison.png"))
```

## COO Signature Overlap

\begin{center}
\textbf{Minimal overlap between COO-specific signatures}
\end{center}

\begin{columns}
\begin{column}{0.33\textwidth}
\centering
\textbf{GCB $\cap$ ABC}\\
\Large 4 genes
\end{column}
\begin{column}{0.33\textwidth}
\centering
\textbf{GCB $\cap$ MHG}\\
\Large 0 genes
\end{column}
\begin{column}{0.33\textwidth}
\centering
\textbf{ABC $\cap$ MHG}\\
\Large 0 genes
\end{column}
\end{columns}

\vspace{0.5cm}
\begin{center}
$\Rightarrow$ \textbf{Each COO subtype has distinct prognostic biology}
\end{center}

# IPI Independence Analysis

## IPI Independence - Methodology

\begin{columns}
\begin{column}{0.5\textwidth}
\textbf{Analysis Design:}
\begin{itemize}
\item 317 GCB samples with IPI data
\item Compare univariate vs multivariate
\item Test if genes remain significant after IPI adjustment
\end{itemize}
\end{column}
\begin{column}{0.5\textwidth}
\textbf{Multivariate Model:}
$$h(t) = h_0(t) \cdot e^{\beta_1 \cdot Gene + \beta_2 \cdot IPI}$$

\vspace{0.3cm}
\textbf{IPI-independent if:}\\
$p_{adjusted} < 0.05$
\end{column}
\end{columns}

## IPI Independence Results

```{r ipi-scatter, out.width="80%"}
knitr::include_graphics(file.path(fig_dir, "ipi_independence_scatter.png"))
```

## IPI Independence Summary

\begin{center}
\Large
\textbf{The prognostic genes are largely IPI-INDEPENDENT}
\end{center}

\vspace{0.5cm}

\begin{columns}
\begin{column}{0.5\textwidth}
\begin{itemize}
\item \textbf{3,037} univariate significant
\item \textbf{2,839} remain after IPI adjustment
\item Only \textbf{701} lose significance
\end{itemize}
\end{column}
\begin{column}{0.5\textwidth}
\begin{itemize}
\item \textbf{93\%} of genes retain significance
\item Gene expression adds prognostic value beyond IPI
\end{itemize}
\end{column}
\end{columns}

# Conclusions

## Key Findings

\begin{enumerate}
\item \textbf{Strong Prognostic Signatures}
    \begin{itemize}
    \item 6,748 significant probes (FDR < 0.05)
    \item Clear separation by risk score
    \end{itemize}

\item \textbf{COO-Specific Biology}
    \begin{itemize}
    \item Minimal overlap between subsets
    \item Each has distinct prognostic determinants
    \end{itemize}

\item \textbf{Biological Themes}
    \begin{itemize}
    \item Protective: T-cell infiltration/immune activation
    \item Adverse: Proliferation/cell cycle
    \end{itemize}

\item \textbf{IPI Independence}
    \begin{itemize}
    \item 93\% genes remain significant after IPI adjustment
    \item Signatures provide additional prognostic information
    \end{itemize}
\end{enumerate}

## Clinical Implications

\begin{columns}
\begin{column}{0.5\textwidth}
\textbf{Risk Stratification:}
\begin{itemize}
\item Refine beyond IPI
\item Identify high-risk patients within IPI groups
\item COO-specific prognostication
\end{itemize}
\end{column}
\begin{column}{0.5\textwidth}
\textbf{Therapeutic Targets:}
\begin{itemize}
\item T-cell function enhancement
\item Cell cycle inhibition
\item Immunotherapy selection
\end{itemize}
\end{column}
\end{columns}

\vspace{0.5cm}
\begin{center}
\textbf{Gene expression signatures could complement clinical staging for personalized treatment decisions}
\end{center}

## Acknowledgments

\begin{center}
\textbf{Data Source}\\
HMRN/Lacy Cohort (GSE181063)

\vspace{0.5cm}
\textbf{Methods}\\
R packages: survival, survminer, enrichR, pheatmap

\vspace{0.5cm}
\textbf{Analysis Pipeline}\\
Cox regression $\rightarrow$ FDR correction $\rightarrow$ Pathway enrichment $\rightarrow$ IPI adjustment
\end{center}

## Thank You

\begin{center}
\Huge Questions?
\end{center}

\vspace{1cm}

\begin{center}
\footnotesize
Analysis code and data available upon request
\end{center}
